Trials / Completed
CompletedNCT02209324
Open-label Study of ASP2151 in Herpes Simplex Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 275 (actual)
- Sponsor
- Maruho Co., Ltd. · Industry
- Sex
- All
- Age
- 16 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
A multicenter, open-label study is conducted to evaluate the efficacy and safety of ASP2151 in patients with herpes simplex (recurrent labial/facial herpes and recurrent genital herpes and Kaposi varicelliform).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP2151 |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2015-07-01
- Completion
- 2015-08-20
- First posted
- 2014-08-05
- Last updated
- 2024-09-27
- Results posted
- 2024-09-27
Locations
3 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02209324. Inclusion in this directory is not an endorsement.